Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1988-3-3
pubmed:abstractText
Hybridomas producing monoclonal antibodies (mAbs) directed against Trichomonas vaginalis (Tv) have been produced in three fusions using mice immunized with live or killed Tv. The ELISA technique was used to test the binding activity of six out of the 48 mAbs produced. It was found that acetone fixation enhanced the binding activity of the antibodies and revealed hidden antigenic determinants. Thirty percent of the mAbs obtained from splenocytes of mice immunized with live Tv were of the IgG3 subtype. Two mAbs of the IgM and IgG3 subtypes demonstrated complement-fixing capacity. Incubation of these mAbs with live Tv and complement at 37 degrees for 30 min lysed the parasites. The lytic process was complement-dependent since in its absence the antibodies only agglutinated the parasites. The mAbs, when partially purified from ascitic fluids, had the same lytic activity as the native preparation. MAbs of the IgG1 subtype which did not fix complement, bound to Tv but did not lyse it. The lytic activity of the mAbs was not inhibited by cervico-vaginal secretions obtained from 14 women. It is suggested that mAbs could be used for diagnostic as well as for therapeutic purposes.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-1172191, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-13753502, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-212851, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-2411656, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-2426199, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-310166, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-3488964, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-3490489, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-3886694, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-4538260, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-4635620, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-6118546, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-6334072, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-6360900, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-6408119, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-6601618, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-6610453, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-6698665, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-688763, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-6983379, http://linkedlifedata.com/resource/pubmed/commentcorrection/2448233-7382255
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0019-2805
pubmed:author
pubmed:issnType
Print
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
63-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Anti-Trichomonas vaginalis monoclonal antibodies inducing complement-dependent cytotoxicity.
pubmed:affiliation
Interpharm, Science-Based Industrial Park, Kiryat Weizmann, Ness-Ziona, Israel.
pubmed:publicationType
Journal Article